4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-25-000186
10% owner sold 17,210 shares at an average $11.97 ($205,932)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2025-04-03 | Sale | −10,321 | $12.23 | $126,226 | 3,131,361 | I |
| Saba Capital Management, L.P. 10% owner | 2025-04-04 | Sale | −6,889 | $11.57 | $79,706 | 3,124,472 | I |
| Open-market sales · 17,210 sh · avg $11.97 · $205,932 | |||||||
Loading xslF345X05/primary_doc.xml…